Works matching IS 03682811 AND DT 2022 AND VI 52 AND IP 1


Results: 16
    1
    2

    Message from the Editor-in-Chief.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 1, p. 1, doi. 10.1093/jjco/hyab190
    By:
    • Kunitoh, Hideo
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 1, p. 29, doi. 10.1093/jjco/hyab170
    By:
    • Yamamoto, Kazuhito;
    • Shinagawa, Atsushi;
    • DiNardo, Courtney D;
    • Pratz, Keith W;
    • Ishizawa, Kenichi;
    • Miyamoto, Toshihiro;
    • Komatsu, Norio;
    • Nakashima, Yasuhiro;
    • Yoshida, Chikashi;
    • Fukuhara, Noriko;
    • Usuki, Kensuke;
    • Yamauchi, Takahiro;
    • Asada, Noboru;
    • Asou, Norio;
    • Choi, Ilseung;
    • Miyazaki, Yasushi;
    • Honda, Hideyuki;
    • Okubo, Sumiko;
    • Kurokawa, Misaki;
    • Zhou, Ying
    Publication type:
    Article
    9
    10
    11
    12

    Performance of Japanese patients in registrational studies.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 1, p. 53, doi. 10.1093/jjco/hyab171
    By:
    • Goto, Yasushi;
    • Arakawa, Sayaka;
    • Shirasawa, Masayuki;
    • Higashiyama, Ryoko;
    • Baba, Keisuke;
    • Masuda, Ken;
    • Shinno, Yuki;
    • Matsumoto, Yuji;
    • Okuma, Yusuke;
    • Yoshida, Tatsuya;
    • Horinouchi, Hidehito;
    • Yamamoto, Noboru;
    • Ohe, Yuichiro
    Publication type:
    Article
    13
    14
    15
    16